Elizabeth Smyth

19.6k total citations · 9 hit papers
142 papers, 9.8k citations indexed

About

Elizabeth Smyth is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Elizabeth Smyth has authored 142 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Pulmonary and Respiratory Medicine, 80 papers in Surgery and 77 papers in Oncology. Recurrent topics in Elizabeth Smyth's work include Gastric Cancer Management and Outcomes (89 papers), Esophageal Cancer Research and Treatment (59 papers) and Colorectal Cancer Treatments and Studies (27 papers). Elizabeth Smyth is often cited by papers focused on Gastric Cancer Management and Outcomes (89 papers), Esophageal Cancer Research and Treatment (59 papers) and Colorectal Cancer Treatments and Studies (27 papers). Elizabeth Smyth collaborates with scholars based in United Kingdom, United States and Italy. Elizabeth Smyth's co-authors include Florian Lordick, David Cunningham, Nicole C.T. van Grieken, Magnus Nilsson, Heike I. Grabsch, Jesper Lagergren, Pernilla Lagergren, William Allum, Andrés Cervantes and Marcel Verheij and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Elizabeth Smyth

130 papers receiving 9.7k citations

Hit Papers

Gastric cancer 2016 2026 2019 2022 2020 2016 2017 2017 2022 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gastric cancer
    2020 3.0k citations Elizabeth Smyth, Magnus Nilsson et al. The Lancet profile →
  2. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    2016 1.1k citations Elizabeth Smyth, William Allum et al. Annals of Oncology profile →
  3. Oesophageal cancer
    2017 831 citations Jesper Lagergren, Elizabeth Smyth et al. The Lancet profile →
  4. Oesophageal cancer
    2017 691 citations Elizabeth Smyth, Jesper Lagergren et al. profile →
  5. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    2022 646 citations Florian Lordick, Elizabeth Smyth et al. Annals of Oncology profile →
  6. Mismatch Repair Deficiency, Microsatellite Instability, and Survival
    2017 365 citations Elizabeth Smyth, Andrew Wotherspoon et al. profile →
  7. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    2022 293 citations Florian Lordick, Magnus Nilsson et al. Annals of Oncology profile →
  8. Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
    2023 124 citations Eric Van Cutsem, Maria Di Bartolomeo et al. The Lancet Oncology profile →
  9. Gastric cancer
    2025 17 citations Raghav Sundar, Kohei Shitara et al. The Lancet profile →

Peers

Elizabeth Smyth
Nicole C.T. van Grieken Netherlands
Eigo Otsuji Japan
Jae‐Ho Cheong South Korea
Sachio Fushida Japan
Simon Law Hong Kong
Hans Prenen Belgium
Daisuke Ichikawa Japan
Kosei Hirakawa Japan
Jianming Xu China
Naureen Starling United Kingdom
Nicole C.T. van Grieken Netherlands
Elizabeth Smyth
Citations per year, relative to Elizabeth Smyth Elizabeth Smyth (= 1×) peers Nicole C.T. van Grieken

Countries citing papers authored by Elizabeth Smyth

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Smyth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Smyth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Smyth more than expected).

Fields of papers citing papers by Elizabeth Smyth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Smyth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Smyth. The network helps show where Elizabeth Smyth may publish in the future.

Co-authorship network of co-authors of Elizabeth Smyth

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Smyth. A scholar is included among the top collaborators of Elizabeth Smyth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Smyth. Elizabeth Smyth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petrillo, Angelica, Lindsey Oudijk, Raghav Sundar, et al.. (2024). EORTC stomach cancer PD-L1 biomarker European initiative: the ASPIRE study protocol. SHILAP Revista de lepidopterología. 5. 100071–100071. 2 indexed citations
2.
3.
Raufi, Alexander G., Lipika Goyal, Elizabeth Smyth, et al.. (2024). CLARITY-PanTumor01: A phase 2 trial of the claudin 18.2-specific antibody-drug conjugate AZD0901 (CMG901) in patients with CLDN18.2-expressing advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS3163–TPS3163. 3 indexed citations
4.
5.
6.
Cella, Chiara Alessandra, Davide Ciardiello, Lorenzo Gervaso, et al.. (2024). Role of the microbiome in the development and treatment of gastric cancer: an overview of the biological and clinical landscape. SHILAP Revista de lepidopterología. 4. 100048–100048. 3 indexed citations
7.
Yang, Jung Wook, et al.. (2024). 1428P Total neoadjuvant FLOT chemotherapy in oesophagogastric adenocarcinoma: An international cohort study. Annals of Oncology. 35. S890–S890. 1 indexed citations
8.
Cutsem, Eric Van, Maria Di Bartolomeo, Elizabeth Smyth, et al.. (2023). Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study. The Lancet Oncology. 24(7). 744–756. 124 indexed citations breakdown →
9.
Devonshire, Ginny, Ahmad Miremadi, Liang Zhuang, et al.. (2023). SO-12 CLDN18.2 expression in resectable gastroesophageal cancers: Associated clinical and molecular signatures and impact of neoadjuvant chemotherapy on intratumor heterogeneity. Annals of Oncology. 34. S166–S167. 1 indexed citations
10.
Zhao, Joseph J., Dominic Wei Ting Yap, Yiong Huak Chan, et al.. (2021). Low Programmed Death-Ligand 1–Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma. Journal of Clinical Oncology. 40(4). 392–402. 112 indexed citations
11.
Fouchardière, Christelle de la, Lore Decoster, Emmanuelle Samalin, et al.. (2021). Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature. Cancer Treatment Reviews. 100. 102289–102289. 5 indexed citations
12.
Wulaningsih, Wahyu, D Foley, Dionysios Dellaportas, et al.. (2021). The role of surgery after prolonged primary chemotherapy for advanced oesophageal adenocarcinoma. Journal of Surgical Oncology. 124(8). 1296–1305. 1 indexed citations
13.
Smyth, Elizabeth, et al.. (2020). Progress and challenges in gastroesophageal cancer. Current Problems in Cancer. 44(6). 100590–100590. 5 indexed citations
14.
Smyth, Elizabeth, Magnus Nilsson, Heike I. Grabsch, Nicole C.T. van Grieken, & Florian Lordick. (2020). Gastric cancer. The Lancet. 396(10251). 635–648. 3025 indexed citations breakdown →
15.
Cunningham, David, et al.. (2018). Peri-operative therapy for operable gastroesophageal adenocarcinoma: past, present and future. Annals of Oncology. 29(6). 1377–1385. 14 indexed citations
16.
17.
Smyth, Elizabeth, Kyriakos Kouvelakis, Clare Peckitt, et al.. (2017). Rash, neutrophil-lymphocyte ratio (NLR) and survival in the REAL3 trial. Annals of Oncology. 28. x60–x60. 1 indexed citations
18.
Lote, Hazel, Domenico Zito, Rosemary Burke, et al.. (2016). MicroRNAs as biomarkers of resistance to HER2 inhibitors in combination with chemotherapy in gastro-oesophageal cancer cell lines. Annals of Oncology. 27. vi549–vi549. 1 indexed citations
19.
Smyth, Elizabeth & David Cunningham. (2012). Targeted Therapy for Gastric Cancer. Current Treatment Options in Oncology. 13(3). 377–389. 59 indexed citations
20.
Patel, Mrinali, Elizabeth Smyth, Paul B. Chapman, et al.. (2011). Therapeutic Implications of the Emerging Molecular Biology of Uveal Melanoma. Clinical Cancer Research. 17(8). 2087–2100. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole C.T. van Grieken Breakdown of academic impact, for papers by Eigo Otsuji Breakdown of academic impact, for papers by Jae‐Ho Cheong Breakdown of academic impact, for papers by Sachio Fushida Breakdown of academic impact, for papers by Simon Law Breakdown of academic impact, for papers by Hans Prenen Breakdown of academic impact, for papers by Daisuke Ichikawa Breakdown of academic impact, for papers by Kosei Hirakawa Breakdown of academic impact, for papers by Jianming Xu Breakdown of academic impact, for papers by Naureen Starling
Rankless by CCL
2026